ALNYLAM PHARMACEUTICALS has a total of 37 patent applications. Its first patent ever was published in 2004. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Taiwan. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are SECARNA PHARMACEUTICALS GMBH & CO KG, SYNVOLUX IP BV and IMSTEM BIOTECHNOLOGY INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 9 | |
#2 | WIPO (World Intellectual Property Organization) | 9 | |
#3 | Taiwan | 6 | |
#4 | Argentina | 3 | |
#5 | Brazil | 3 | |
#6 | China | 2 | |
#7 | EPO (European Patent Office) | 2 | |
#8 | Australia | 1 | |
#9 | Canada | 1 | |
#10 | New Zealand | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry | |
#4 | Foods and drinks | |
#5 | Environmental technology | |
#6 | Agriculture |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Sugars | |
#5 | Enzymes | |
#6 | Acyclic or carbocyclic compounds | |
#7 | Climate change mitigation in goods production | |
#8 | Special acyclic compounds | |
#9 | Peptides | |
#10 | Animal care |
# | Name | Total Patents |
---|---|---|
#1 | Manoharan Muthiah | 19 |
#2 | Rajeev Kallanthottathil G | 12 |
#3 | Fitzgerald Kevin | 9 |
#4 | Maier Martin | 9 |
#5 | Milstein Stuart | 8 |
#6 | Charisse Klaus | 7 |
#7 | Bettencourt Brian | 7 |
#8 | Querbes William | 6 |
#9 | Kuchimanchi Satyanarayana | 5 |
#10 | Frank-Kamenetsky Maria | 4 |
Publication | Filing date | Title |
---|---|---|
BR112020022546A2 | extrahepatic delivery | |
TW201726148A | Methods and compositions for treating a SERPINC1-associated disorder | |
TW201718620A | Xanthine dehydrogenase (XDH) iRNA compositions and methods of use thereof | |
US2013317081A1 | Serpinc1 iRNA compositions and methods of use thereof | |
US2010222417A1 | Compostions and methods for enhancing oligonucleotide delivery across and into epithelial tissues | |
US2005256069A1 | IRNA agents with biocleavable tethers | |
WO2004090108A2 | Irna conjugates | |
WO2004064737A2 | Therapeutics compositions |